Compounded hormone therapy and weight-loss program designed to protect bone density & relieve menopause symptoms
Compounded hormone therapy and weight-loss program designed to protect bone density & relieve menopause symptoms

For Physicians

Every woman goes through menopause. Some women are lucky and have fewer symptoms than others, although research shows that 70-80% of women do suffer significant symptoms.

What The Data Says

The North American Menopause Society (NAMS)

Hormone therapy (HT) remains the most effective treatment for vasomotor symptoms (VMS) and the genitourinary syndrome of menopause (GSM) and has been shown to prevent bone loss and fracture.

BMD During the Pre or Early Perimenopause

Bone loss accelerates substantially in late perimenopause and continues at a similar pace in the first postmenopausal years.

Body Weight and Ethnicity In Relation to BMD

A similar study of bone mineral density changes during menopause reveals that bone loss accelerates substantially in the late perimenopause and continues at a similar pace in the first postmenopausal years. Additionally, the rate of postmenopausal bone mineral changes is related to body weight and not ethnicity.

Did You Know?

Hip fractures

More women will die annually of the ramifications of a broken hip, than from breast cancer.

How long symptoms last

The average length of symptoms during menopause is 7 years. This number can vary from woman to woman and can even last anywhere from 10 to 15 years.

Have a patient who may benefit?

Patients can start with the 2-minute assessment.